Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children
Part of paid clinical trials in Tuscaloosa, Alabama.
- Sponsor
- Carelon Research
- Study ID
- NCT05287412
- Status
- Active Not Recruiting
Conditions
- Multisystem Inflammatory Syndrome in Children (MIS-C)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 21 Years
- Healthy Volunteers
- Not accepted
Study Details
Multi-system Inflammatory Syndrome in Children (MIS-C) is a new condition related to COVID-19, the study investigators are still learning about its causes, effects, and long-term impact. "Long-Term Outcomes after the Multisystem Inflammatory Syndrome In Children", the Coronavirus MUSIC Study, is a research study funded by NIH and the National Heart, Lung, and Blood Institute. The study investigators hope to enroll at least 900 young people with MIS-C at children's medical centers in the U.S. and Canada. This research study will help us learn more about MIS-C and its effects on the long-term health of children.
Key Dates
- First listed
- Mar 18, 2022
- Start date
- Sep 30, 2020
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 1,200 participants (actual)
Primary Outcome Measure
worst-ever LV ejection fraction [ Time Frame: hospital admission through 5 years post-hospitalization ]
Locations (32)
Find similar trials in Tuscaloosa, AL
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Little Rock, Arkansas